Search, filter, and browse every compound — evidence and regulatory status shown plainly. Topic labels describe areas of research, never guaranteed benefits.
The molecule behind the mainstream GLP-1 conversation, with large-scale FDA-approved trial evidence behind specific products.
Also searched as: Ozempic, Wegovy, Rybelsus
Metabolic HealthA dual GIP/GLP-1 receptor agonist, distinct from single-pathway GLP-1 drugs — trial sponsors have reported large head-to-head weight-loss results, driving significant clinical and consumer discussion.
Also searched as: Mounjaro, Zepbound
Metabolic HealthA triple-pathway (GIP/GLP-1/glucagon) investigational agonist. Early manufacturer-reported weight-loss figures are large but not yet independently published or peer-reviewed.
Metabolic HealthA fitness/recovery community favorite backed mostly by animal research and anecdotal reports, not human trials.
Recovery & Tissue RepairA copper-binding peptide with real cosmetic-science backing for skin effects, though broader “longevity” claims outpace that evidence.
Also searched as: Copper Peptide
Skin & AppearanceFrequently paired with BPC-157 in recovery discussions, resting on animal-model research rather than independent human trials.
Recovery & Tissue RepairA longer-acting GHRH-pathway compound often discussed alongside ipamorelin as a “stack.”
Hormone SignalingA growth-hormone secretagogue studied for receptor selectivity — proposed to affect other hormones less than some older compounds in its class, though this has not been established as a safety advantage in controlled trials.
Hormone SignalingFDA-approved for a specific, narrow indication — a useful reference point for strong evidence, not a general fat-loss approval.
Also searched as: Egrifta, Egrifta SV, Egrifta WR
Metabolic HealthHormone SignalingA GHRH-pathway peptide with real FDA approval history, though the approved product is discontinued and current use is compounded.
Also searched as: Geref, Sermorelin Acetate
Hormone SignalingAn orally active ghrelin-receptor agonist — not technically a peptide — with discontinued pharmaceutical development.
Also searched as: Ibutamoren, MK-0677
Hormone SignalingAn emerging mitochondrial-derived peptide drawing early longevity and exercise-science attention ahead of much human data.
Metabolic HealthHealthy AgingAn early-stage anti-inflammatory peptide of interest for a mechanism distinct from other alpha-MSH-derived compounds.
Immune ResearchRecovery & Tissue RepairA longevity-research fixture tied to telomerase and circadian hypotheses, with limited independent replication so far.
Also searched as: Epithalon
Healthy AgingAn immune-modulating peptide approved as a pharmaceutical in some countries, but not in the US.
Also searched as: Zadaxin, TA1, Thymosin Alpha 1
Immune ResearchOne of the few FDA-approved compounds here, though most current interest is for off-label use beyond its approved population.
Also searched as: Bremelanotide, Vyleesi
Sexual HealthNo compounds match these filters.
Try a different combination, search by an alias/brand name, or .